Residential College | false |
Status | 已發表Published |
Synergistic anti-tumor effect of a TGFβ inhibitor and cyclophosphamide | |
Xin Chen1,2; Lalage M. Wakefield3; Joost J. Oppenheim2 | |
2014 | |
Source Publication | Oncoimmunology |
ISSN | 2162-4011 |
Volume | 3Issue:4 |
Abstract | In a mouse model of breast carcinoma, the combination of cyclophosphamide and transforming growth factor β1,2,3 (TGFβ1,2,3)-targeting antibody achieved superior antineoplastic effects. This novel paradigm of synergistic chemoimmunotherapy promises to improve the clinical outcome of cancer patients with micrometastases, and thus deserves further investigation. |
Keyword | Anti-tgfβ Antibody Chemoimmunotherapy Cyclophosphamide |
DOI | 10.4161/onci.28247 |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Oncology ; Immunology |
WOS Subject | Oncology ; Immunology |
WOS ID | WOS:000339955700005 |
Scopus ID | 2-s2.0-84902590233 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | University of Macau |
Affiliation | 1.Basic Science Program; Leidos Biomedical Research, Inc.; Frederick National Laboratory for Cancer Research; Frederick, MD USA 2.Laboratory of Molecular Immunoregulation; Cancer Inflammation Program; Center for Cancer Research; National Cancer Institute; Frederick, MD USA 3.Laboratory of Cancer Biology and Genetics; Center for Cancer Research; National Cancer Institute; Frederick, MD USA |
Recommended Citation GB/T 7714 | Xin Chen,Lalage M. Wakefield,Joost J. Oppenheim. Synergistic anti-tumor effect of a TGFβ inhibitor and cyclophosphamide[J]. Oncoimmunology, 2014, 3(4). |
APA | Xin Chen., Lalage M. Wakefield., & Joost J. Oppenheim (2014). Synergistic anti-tumor effect of a TGFβ inhibitor and cyclophosphamide. Oncoimmunology, 3(4). |
MLA | Xin Chen,et al."Synergistic anti-tumor effect of a TGFβ inhibitor and cyclophosphamide".Oncoimmunology 3.4(2014). |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment